We are delighted for our colleague Bastian Fleitz, who recently became the father of twins! Bastian has been working with PharmaKorell as a Senior Consultant and Qualified Person since May 2022.

To focus on this new chapter, he will serve in a significantly reduced capacity at PharmaKorell until the end of the year. In the meantime, we have temporarily redistributed his responsibilities within the team.

We warmly wish Bastian and his family all the very best during this special time!

Our first visit to the Making & Distributing Pharmaceuticals UK was a great success. We were able to establish numerous valuable new contacts. A particular highlight was the diverse programme of talks, especially the presentation by Dr Atheer Awad on On Demand 3D Printing of Pharmaceuticals .

A key topic for us was, of course, the import of medicinal product batches between the UK and the EU – an area in which PharmaKorell was able to contribute its many years of experience. Many visitors specifically sought us out to explore this topic.

A heartfelt thank you to the organisers and attendees of the event. We are already looking forward to taking part again next year!

Today we celebrate a significant milestone: since our founding in 2007 at the Innocel Innovations-Center Lörrach, we have grown from an ambitious start-up into a medium-sized pharmaceutical consulting company.

With locations in Lörrach, Munich and Basel, we have built strong partnerships with over 180 international clients over the years. Our multidisciplinary team of 26 experts, including 15 active, registered Qualified Persons, forms the heart of PharmaKorell and is the key to our continued success.

We thank our clients, our partners, and our dedicated team for their trust and commitment. We look forward to the future chapters we will experience together.

We are delighted to once again take part in the Swiss Biotech Day on 5 and 6 May. As a pharmaceutical consulting firm with a Swiss base in Basel, we are proud to be a member of the prestigious Swiss Biotech Association.

Our programme this year includes attending selected events and panel discussions:

May 4, 17:30 – 20:30 | Welcome Reception

May 5, 10:00 – 11:00 | Swiss Biotech Association General Assembly

May 5, 15:30 – 16:15 | How to reach more patients faster: the promise of international collaboration and shared regulatory approval pathways

Moderation Panelists

May 5, 17:30 – 18:15 | Enhancing Europe’s Role as a Global Hub for Oncology Trials

Moderation Panelists

May 6, 15:00 – 15:45 | Radioligand Therapies – Opportunities and Challenges for Switzerland and Globally

Moderation Panelists

May 6, 16:00 – 16:45 | From Innovation to Patient: Swissmedic’s Role in Accelerating Drug Development and Patient Access

Moderation Panelists

We look forward to engaging with esteemed international experts in the biotechnology sector.

PharmaKorell will be represented at the Swiss Biotech Day in Basel on 5 – 6 May 2025 by Dr Konrad Dreizler, Dr Ulrich Korell and Dr Frank Wienen.

We invite you to join us for discussions on a wide range of topics, including quality management, EU QP certification, provision of key personnel such as Responsible Persons (FvP), cross-border pharmaceutical services, business development, as well as pharmaceutical logistics and packaging.

We look forward to engaging with you in an informal setting and working together to find solutions to your challenges. 

Please don’t hesitate to contact us to arrange a meeting.

Due to the growing number of client projects, PharmaKorell has taken into operation a new, larger packaging room. The first packaging order in this new area was for a double-blind study in the EU.

Packaging projects at our company are always meticulously managed and supervised by two experienced professionals who also actively participate; in this case by Dr. Matthias Barth, Head of Quality Control, and Dr. Ulrich Korell, acting as Deputy Head of Production. 

On this occasion, new team members were also trained: Monika Kaur Wagner, our future Head of Quality Assurance, and Dr. Konrad Dreizler, another Deputy Head of Production. PharmaKorell offers QP batch release for the EU, EEA, Switzerland, and the UK for supplying clinical studies – complemented by comprehensive packaging and logistics solutions. 

We print labels in-house, procure suitable secondary packaging materials, and organise GDP-compliant thermal transport according to customer-specific requirements, e.g. deep-frozen for particularly temperature-sensitive products.

After his international career in the pharmaceutical industry and another 16 productive years at PharmaKorell, Dr Robert Buck has decided to finally hand over his projects to Dr Helene Geese and Bastian Fleitz and to retire permanently. 

His entry into PharmaKorell in 2009, when the company was still in its infancy, was originally meant to be just a short-term consultancy. However, what began as a temporary engagement developed into a long-standing collaboration. In this blog post, we look back on Robert’s significant contributions and explore the valuable experiences he gathered. Robert’s story shows that it’s never too late to start a new chapter.

Robert, you started as a consultant at PharmaKorell in 2009 when it was still a very small company. What motivated you to do so?

After taking early retirement from the corporate world, I still felt too youthful and energetic to fully retire. PharmaKorell offered me the opportunity to work as a freelance employee with a self-chosen workload. The work was very varied, enjoyable, and gave me the feeling of still being needed and appreciated with my experience. I was able to look after my clients very independently from my own office. What was originally planned as three years of activity at PharmaKorell ultimately became 16 years.

What were your highlights during your time at PharmaKorell?

A highlight was always successfully passing a regulatory inspection with a client. It showed me that I am technically up-to-date and have done good work for my client. Another highlight was creating the QA system when setting up a subsidiary for a client. Additional highlights included two successful product launches on the European market. With my QP release, I was able to help patients receive new medications for better treatment of their illnesses.

What advice would you give to potential new employees at PharmaKorell?

Be open to new tasks and customers, enjoy new challenges, be ready to take responsibility, and bring a lot of experience from your previous professional activity. Clients come to PharmaKorell because they need support and expertise for their companies. You must deliver this support and expertise. The work at PharmaKorell requires commitment, flexibility, creativity, and a sense of proportion in solving problems.

How does the working method at PharmaKorell differ from that at large pharmaceutical companies?

I learned more in the years at PharmaKorell than I had previously in 28 years in the pharmaceutical large industry. The work at PharmaKorell is more varied and often more responsible than in large companies. At PharmaKorell, you work with different clients, often on quite different topics and tasks. You come into contact with a variety of pharmaceutical dosage forms, from active substance production to market supply, including GMP audits, support during regulatory inspections, and consultancy on GMP questions.

Robert, what will you do with all your free time in the future?

I have a large garden and five grandchildren. I also very much enjoy travelling to exotic countries. I will now have more time for this. And I look forward to the fact that when I get up in the morning, I no longer have to ask what I must do today, but what I would like to do today.

We are excited to participate in the Making & Distributing Pharmaceuticals exhibition in Coventry this April. Amongst other topics, our involvement enables us to learn firsthand about the latest developments and challenges of 3D printing in pharmaceutical production.

Ensuring quality and compliance when using this revolutionary technology in the pharmaceutical environment is a fascinating topic. We are eager to engage with other GMP experts who are also professionally involved in this field.

We will be attending the following events:

29 April

8:45 AM A Journey to the Wonderful World of 3D Printing CITRS Prof. Dimitrios Lamprou

9:30 AM 3D Printed Personalised Medications at the Point of Care Prof. Dennis Douroumis

10:00 AM On Demand 3D Printing of Pharmaceuticals Atheer Awad

2:00 PM MHRA Regulatory & Compliance Trends, and Industry Challenges from an MHRA Perspective Peter Brown

30 April

10:00 AM Panel Discussion: Northern Ireland Pharma Supply Chain and the Windsor Framework. Sean Curley, Brian Anderton, Robert Hardy, Peter Brown

Meet PharmaKorell at the Making & Distributing Pharmaceuticals UK in Coventry from 29 to 30 April 2025. Our Managing Director and Founder, Dr Ulrich Korell, along with Dr Lucia Vitellozzi, our Business Development Manager and Qualified Person, are looking forward to meeting you.

As an independent German pharmaceutical consulting firm, we have been supporting over 180 pharmaceutical and biotech companies worldwide in more than 30 countries since 2007 with a team of over 20 experts.

For British pharmaceutical manufacturers, we import British medicines into the EU and handle EU-QP release for marketing or clinical trials. We also take care of customs clearance and distribution. With us, the EU external border is no longer a competitive disadvantage for British manufacturers.

For appointment scheduling, please send us an email to info@pharmakorell.com.

Since the beginning of February, Konrad has been strengthening our team in Lörrach as a Senior Consultant and Qualified Person.

Following his PhD in Biology from the University of Hohenheim in Stuttgart, Konrad has continuously expanded his expertise in pharmaceutical production and safety.

Konrad brings extensive experience from over five years at Catalent Pharma Solutions, starting with the primary responsibility for the review and release of master manufacturing instructions from both technical and GMP perspectives. He initially took on project leadership for genetic engineering work and later served as the officer for biological safety. After moving to the Quality Assurance department, he provided QP support in the certification of clinical trial materials. Most recently, as a Qualified Person, he managed comprehensive projects related to clinical studies before joining us.

The PharmaKorell team is excited to have Konrad on board and looks forward to a successful collaboration.